Monoclonal Antibody Treatment for COVID-19

There is emerging evidence for the efficacy of monoclonal antibody (mAb) treatment for early COVID disease. Both Lilly and Regeneron have conducted randomized control trials to test this intervention. Based on the initial results of these trials, the FDA gave an EUA for both treatments with a set of inclusion criteria to focus the treatment … Continue reading Monoclonal Antibody Treatment for COVID-19